Plasma Aβ 42 as a biomarker of prodromal Alzheimer's disease progression in patients with amnestic mild cognitive impairment: Evidence from the PharmaCog/E-ADNI Study
Journal article published in 2019 by
D. Albani,
M. Marizzoni,
C. Ferrari,
F. Fusco,
L. Boeri,
I. Raimondi 
,
J. Jovicich,
C. Babiloni,
A. Soricelli,
R. Lizio,
S. Galluzzi,
L. Cavaliere,
M. Didic,
P. Schönknecht,
J. L. Molinuevo
and other authors.
,
J. Jovicich,
C. Babiloni,
A. Soricelli,
R. Lizio,
S. Galluzzi,
L. Cavaliere,
M. Didic,
P. Schönknecht,
J. L. Molinuevo
and other authors.
